Zanubrutinib
Update Venetoclax in CLL
Ibrutinib Plus Bendamustine and Rituximab
Acalabrutinib
NCCN Guidelines for Patients for CLL
Cancer.gov
ASH: COVID-19 Resources for Managing Blood Cancers
UpToDate